Ariel Hurley Blueprint Medicines Corp (BPMC) insider trading activity

Ariel Hurley is PRINCIPAL ACCOUNTING OFFICER of Blueprint Medicines Corp. Currently has a direct ownership of 16,944 shares of BPMC, which is worth approximately $1.5 Million. The most recent transaction as insider was on Nov 16, 2021, when has been sold 1,950 shares (Common Stock) at a price of $114.28 per share, resulting in proceeds of $222,846. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.9K

13.21% 3M change

13.62% 12M change

Total Value Held $1.5 Million

Ariel Hurley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 16 2021	SELL Open market or private sale	$222,846 $114.28 p/Share	1,950 Reduced 16.19%	10,097 Common Stock
Nov 16 2021	BUY Exercise of conversion of derivative security	$16,692 $8.56 p/Share	1,950 Added 13.93%	12,047 Common Stock
Sep 23 2021	SELL Open market or private sale	$66,000 $110.0 p/Share	600 Reduced 5.61%	10,097 Common Stock
Sep 23 2021	BUY Exercise of conversion of derivative security	$9,006 $15.01 p/Share	600 Added 5.31%	10,697 Common Stock
Sep 13 2021	SELL Open market or private sale	$60,000 $100.0 p/Share	600 Reduced 5.61%	10,097 Common Stock
Sep 13 2021	BUY Exercise of conversion of derivative security	$9,006 $15.01 p/Share	600 Added 5.31%	10,697 Common Stock
Aug 17 2021	SELL Open market or private sale	$124,106 $91.93 p/Share	1,350 Reduced 11.79%	10,097 Common Stock
Aug 17 2021	BUY Exercise of conversion of derivative security	$7,209 $5.34 p/Share	1,350 Added 10.55%	11,447 Common Stock
Jun 01 2021	SELL Open market or private sale	$21,726 $91.67 p/Share	237 Reduced 2.29%	10,097 Common Stock
May 17 2021	SELL Open market or private sale	$290,225 $95.0 p/Share	3,055 Reduced 23.23%	10,097 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	$7,209 $5.34 p/Share	1,350 Added 9.31%	13,152 Common Stock
Mar 04 2021	SELL Open market or private sale	$75,347 $87.92 p/Share	857 Reduced 6.77%	11,799 Common Stock
Mar 03 2021	SELL Open market or private sale	$50,702 $98.45 p/Share	515 Reduced 3.91%	12,656 Common Stock
Mar 01 2021	SELL Open market or private sale	$169,167 $99.51 p/Share	1,700 Reduced 11.43%	13,171 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$9,078 $5.34 p/Share	1,700 Added 10.26%	14,871 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	3,187 Added 19.48%	13,171 Common Stock
Dec 01 2020	SELL Open market or private sale	$113,703 $109.54 p/Share	1,038 Reduced 9.42%	9,984 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$7,920 $8.8 p/Share	900 Added 7.64%	10,884 Common Stock
Nov 16 2020	SELL Open market or private sale	$171,564 $100.92 p/Share	1,700 Reduced 14.55%	9,984 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	$9,078 $5.34 p/Share	1,700 Added 12.7%	11,684 Common Stock
Oct 07 2020	SELL Open market or private sale	$60,000 $100.0 p/Share	600 Reduced 5.67%	9,984 Common Stock
Oct 07 2020	BUY Exercise of conversion of derivative security	$5,280 $8.8 p/Share	600 Added 5.36%	10,584 Common Stock

Ariel Hurley

PRINCIPAL ACCOUNTING OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Value

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC

Account